Terumo Corp. (OTCMKTS:TRUMY - Get Free Report)'s share price gapped up prior to trading on Monday . The stock had previously closed at $17.85, but opened at $18.60. Terumo shares last traded at $17.96, with a volume of 6,522 shares changing hands.
Terumo Stock Down 0.5%
The company has a 50-day moving average price of $17.58 and a 200 day moving average price of $18.20. The firm has a market capitalization of $25.82 billion, a PE ratio of 30.60 and a beta of 0.79. The company has a debt-to-equity ratio of 0.07, a current ratio of 2.64 and a quick ratio of 1.53.
Terumo (OTCMKTS:TRUMY - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.20 EPS for the quarter, beating the consensus estimate of $0.17 by $0.03. Terumo had a return on equity of 9.19% and a net margin of 12.09%.The business had revenue of $1.76 billion for the quarter, compared to the consensus estimate of $1.80 billion.
About Terumo
(
Get Free Report)
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.
Further Reading
Before you consider Terumo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Terumo wasn't on the list.
While Terumo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.